Alkabel-SR 0.0582 mg / 0.311 mg / 48.6 mg / 0.0195 mg Extended Release Oral Tablet
RxNorm 1048290
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1048290 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Alkabel-SR 0.0582 mg / 0.311 mg / 48.6 mg / 0.0195 mg Extended Release Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
Alkabel (atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.311 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg) Extended Release Oral Tablet
(Atom ID: 6354054)
TMSY
Tall Man Lettering Synonym (TMSY):
Alkabel (atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.311 mg / PHENobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg) Extended Release Oral Tablet
(Atom ID: 6375389)
PSN
Prescribable Name (PSN):
Alkabel-SR 0.0582 mg / 0.311 mg / 48.6 mg / 0.0195 mg Extended Release Oral Tablet
(Atom ID: 6364237)
SBD
Semantic Branded Drug (SBD):
Atropine sulfate 0.0582 mg / hyoscyamine sulfate 0.311 mg / phenobarbital 48.6 mg / scopolamine hydrobromide 0.0195 mg Extended Release Oral Tablet [Alkabel]
(Atom ID: 12370285)
TMSY